Replies to post #152489 on Biotech Values

[mcbio]

These guys are going to have to raise more capital

They just said at Lazard they have existing cash to get them well into 2014. Maybe some kind of offering by mid-2013 if no partner by that point but it's not like they are almost out of cash.

Sounded more like all I got was excuses like, "potential partners want to see results of FDA talks" or "potential partners want to see more clarity on follow-up data". So, it's not like all of a sudden after getting clarity on those two things, a partner is going to up and run to them with the signed term-sheets. I would be very surprised, actually, to see them ever partner '011, and go it alone through all these trials, and just keep on diluting like every other JV biotech management team seems to be doing.

Having said that, IF '011 results are outstanding (i can't see how they will be MASSIVELY outstanding with the small N), they probably should keep it 100%.

Who knows about partnering as that's impossible to predict? I'm just hoping in the short-term for a positive update next month and some upward movement in the share price. At the current valuation, I'm more than willing to continue to hold for awhile.